Study of impact of COVID-19 infection on ectopic pregnancy in a tertiary care center

Background: COVID-19 is an infectious disease caused by a recently discovered coronavirus (SARS-CoV-2). Most of the people infected with the coronavirus experience mild to moderate respiratory illness and recover without requiring any special treatment. In current study we have studied impact of COVID-19 pandemic on clinical outcome and management of ectopic pregnancy.Methods: Women with confirmed or suspected ectopic pregnancy admitted in emergency for further management and tested via nasopharyngeal (NP) or oropharyngeal swab for SARS-CoV-2 using reverse transcriptase polymerase chain reaction (RT-PCR) from April 1, 2020 to November 30, 2020 were included in the study.Results: In our study out of 32 case of ectopic pregnancy, 3 patients were COVID-19 positive. Total non COVID-19 patients were 29. Out of 32 ectopic pregnancies only 4 were unruptured ectopic pregnancy and rest 28 had ruptured ectopic pregnancy. Mortality among ectopic pregnancy was noted only in 1 case (3.12%).Conclusions: Timely diagnosis and initiating management at first point of care can reduce the morbidity and mortality due to ectopic pregnancy. Patient’s knowledge attitude and awareness will be achieved through health education. Women with clinical signs and physical symptoms of a ruptured ectopic pregnancy, such as hemodynamic instability or an acute abdomen, should be evaluated and treated urgently. In pandemic situation where some part of hospital facilities devoted to COVID-19 patients, so planned distribution of resources to tackle medical emergency will bear fruitful positive outcome

Survey on common practice in management of preeclampsia by obstetricians

Background: Approximately 72,000 pregnant women all over the world die every year due to direct or indirect complications related to eclampsia and severe preeclampsia. Incidence of hypertensive disorders in pregnancy in India is found to be 10.08% as per the data collected by the National Eclampsia Registry (NER). Here we present the results of a survey conducted among obstetricians in India to know the common practices in the management of pre-eclampsia followed in our country.Methods: Observational study of survey which was conducted for the period of 1 month from 22nd May 2020 to 22nd June 2020. Questionnaire was prepared on surveyheart.com and sent to obstetricians via Social media platforms to the members of FOGSI. all answers 'collected' and results were prepared from given answers. The survey was answered online by 289 obstetricians.Results: For mild to moderate pre-eclampsia Labetalol is still first line antihypertensive agent being used by many of the obstetricians. In our study also we found out Tab Labetalol 100mg BD is the most preferred type (278, 96.19%) of first line anti-hypertensive in cases of pre-eclampsia followed by Cap Nifedipine 5mg QID and Tab Amlodipine 5mg OD respectively.Conclusions: Comprehensive educational efforts and skill building modules are need of hour to keep every practicing obstetrician regarding recent advances in standard practice protocols.With close monitoring of all cases and well selected anti-hypertensive treatment, it is possible to achieve favourable outcomes for the mother and the baby